RemeGen Co., Ltd.
REGMF
$1.50
-$0.54-26.47%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 54.08% | 60.44% | 50.40% | 32.81% | -53.01% |
| Total Other Revenue | 50.58% | -9.77% | 55.32% | 55.32% | 7,257.65% |
| Total Revenue | 54.07% | 59.94% | 50.42% | 32.93% | -52.80% |
| Cost of Revenue | 40.93% | 50.24% | 46.21% | -11.83% | -25.81% |
| Gross Profit | 58.05% | 63.11% | 51.85% | 57.88% | -57.49% |
| SG&A Expenses | 7.48% | 10.06% | 31.12% | 45.37% | 53.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -86.91% | -33.61% | -172.20% | -247.80% | -149.66% |
| Total Operating Expenses | 22.36% | 28.56% | 31.41% | 26.31% | 25.23% |
| Operating Income | -1.51% | -9.32% | -19.09% | -21.98% | -1,540.68% |
| Income Before Tax | -13.14% | -26.19% | -42.30% | -43.49% | -514.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.14% | -26.19% | -42.30% | -43.49% | -514.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.14% | -26.19% | -42.30% | -43.49% | -514.06% |
| EBIT | -1.51% | -9.32% | -19.09% | -21.98% | -1,540.68% |
| EBITDA | 1.80% | -6.49% | -17.09% | -19.71% | -815.49% |
| EPS Basic | -14.24% | -28.03% | -43.87% | -40.22% | -426.82% |
| Normalized Basic EPS | -8.45% | -18.71% | -30.20% | -27.95% | -458.77% |
| EPS Diluted | -14.24% | -28.03% | -43.87% | -40.22% | -426.82% |
| Normalized Diluted EPS | -8.45% | -18.71% | -30.20% | -27.95% | -458.77% |
| Average Basic Shares Outstanding | -1.12% | -1.60% | -1.04% | 1.59% | 6.35% |
| Average Diluted Shares Outstanding | -1.12% | -1.60% | -1.04% | 1.59% | 6.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2.85% | -5.67% | -2.20% | -2.29% | -1.86% |
